Skip to content

Clinical trials

Phase 3 Heart Failure trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Bulgaria Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20121
20131
20143
20162
20175
20181
20192
20201
20231
20244
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting10
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AstraZeneca5
Bayer3
Novo Nordisk A/S3
Amgen2
Boehringer Ingelheim2
Janssen Research & Development, LLC2
American Regent, Inc.1
Biogen1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure33
Cardiovascular Diseases3
Stroke3
Coronary Artery Disease2
Hypertension2
Obesity2
Renal Insufficiency, Chronic2
Ventricular Dysfunction, Left2
Acute Coronary Syndrome1
Anemia1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.